"The Handbook of Systemic Drug Treatment in Dermatology helps prescribers and patients make rational decisions about drug treatment while considering known risks and potential unwanted effects. Written for dermatologists, family practitioners, pharmacists, and specialist nurses, this completely revised and updated third edition of a bestseller provides an accessible and concise aid to prescribing and monitoring systemic dermatologic therapy. For each drug or drug class, the book lists its classification,mode of action, formulations, dosages, suggested regimens, contraindications, important drug interactions, adverse effects, patient information, and more. This third edition includes new classes of drugs as well as information on updated guidelines for prescribing and monitoring established drugs. FROM REVIEWS OF PREVIOUS EDITIONS "This updated edition includes new arrivals... Quite simply, it is indispensable! I have it with me in every clinic and often refer to it in discussions with pharmacists (who have been known to borrow my copy and forget to return it)." Dermatology in Practice "an outstanding resource that helps to alleviate worrying by providing precise guidelines and advice in managing our most infirm patients who require these medications" SkinMed"--
This book helps prescribers and patients make rational decisions about drug treatment while considering known risks and potential unwanted effects. This third edition includes new classes of drugs as well as information on updated guidelines for prescribing and monitoring established drugs.
Arvustused
This wonderful reference book is a delight to read.
- Doody's Review
Preface |
|
ix | |
Contributors |
|
x | |
|
|
xiv | |
|
|
1 | (5) |
|
Peter C.M. van de Kerkhof |
|
|
Chapter 2 Acne Antibiotics |
|
|
6 | (7) |
|
|
|
|
|
13 | (6) |
|
|
|
|
19 | (9) |
|
|
|
Chapter 5 Antibiotics Commonly Used for Skin Infections |
|
|
28 | (14) |
|
|
|
|
|
42 | (19) |
|
|
|
61 | (6) |
|
|
|
Chapter 8 Antivirals for Herpesviruses |
|
|
67 | (7) |
|
|
|
74 | (4) |
|
|
|
78 | (6) |
|
|
|
Chapter 11 Azole Antihelminths |
|
|
84 | (4) |
|
|
|
88 | (5) |
|
|
|
93 | (6) |
|
|
|
|
99 | (5) |
|
|
|
Chapter 15 Corticosteroids |
|
|
104 | (8) |
|
|
Chapter 16 Cyclophosphamide |
|
|
112 | (8) |
|
|
|
|
|
120 | (6) |
|
|
|
Chapter 18 Dimethyl Fumarate |
|
|
126 | (5) |
|
|
|
Chapter 19 Interleukin-4/13 Inhibitors |
|
|
131 | (6) |
|
|
|
Chapter 20 Interleukin (IL)-12/23 and IL-23 Inhibitors |
|
|
137 | (7) |
|
|
|
Chapter 21 Interleukin-17 Inhibitors |
|
|
144 | (7) |
|
|
Christopher E.M. Griffiths |
|
|
|
151 | (8) |
|
|
|
159 | (5) |
|
|
|
Chapter 24 Intravenous Immunoglobulin |
|
|
164 | (6) |
|
|
Chapter 25 Janus Kinase (JAK) Inhibitors |
|
|
170 | (7) |
|
|
|
|
Chapter 26 Malignant Melanoma Drug Treatments |
|
|
177 | (18) |
|
|
|
|
195 | (8) |
|
|
|
Chapter 28 Mycophenolate Mofetil |
|
|
203 | (5) |
|
|
|
|
208 | (4) |
|
|
|
|
Chapter 30 Potassium Iodide |
|
|
212 | (3) |
|
|
|
215 | (5) |
|
|
|
220 | (8) |
|
|
|
228 | (5) |
|
|
Chapter 34 Sulfapyridine and Sulfamethoxypyridazine |
|
|
233 | (6) |
|
|
|
239 | (6) |
|
|
|
Chapter 36 Tumour Necrosis Factor Antagonists |
|
|
245 | (8) |
|
|
Christopher E.M. Griffiths |
|
|
|
253 | (4) |
|
|
|
Chapter 38 Systemic Therapy in Children and Young People |
|
|
257 | (9) |
|
|
Chapter 39 Systemic Therapy and Kidney Disease |
|
|
266 | (4) |
|
|
Chapter 40 Systemic Therapy and Liver Disease |
|
|
270 | (9) |
|
|
|
Chapter 41 Systemic Therapy in Older People |
|
|
279 | (5) |
|
|
|
Index |
|
284 | |
Edited by
Sarah H. Wakelin, BSc, MB, BS, FRCP, Consultant Dermatologist and Honorary Seniro Lecturer, Imperial College Healthcare NHS Trust, London, UK
Howard I. Maibach, MD, Professor of Dermatology, Department of Dermatology, University of California, San Francisco, USA
Clive B. Archer, BSc, MBBS, MSc Med Ed, MD, PhD (Lond), FRCP, Consultant Dermatologist, St Johns Institute of Dermatology, Guys and St. Thomas Hospitals NHS Foundation Trust, Honorary Professor of Dermatology and Immunopharmacology (UCLan) and Honorary Senior Lecturer (KCL), London, UK